{"entity":{"type":"insider","cik":"0001590102","url":"/insider/0001590102","json_url":"/insider/0001590102.json","name":"Mehra Anand","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":76,"n_filings":40,"first":"2013-10-30","last":"2024-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Mehra Anand","source":"filing","n_filings":40,"first_seen":"2013-10-30","last_seen":"2024-11-20"}],"transactions":[{"id":2449621,"accession":"0001415889-24-027348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-027348","line_url":"/filing/0001415889-24-027348#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":1499998.5,"total_display":"1,499,998.50","total_whole":"1,499,999","shares_owned_after":710030.0,"shares_owned_after_display":"710,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-20","scope":"insider"},{"id":8699222,"accession":"0001104659-19-065582","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-065582","line_url":"/filing/0001104659-19-065582#line-1","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"NextCure, Inc.","issuer_ticker":"NXTC","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; Sofinnova Venture Partners IX, L.P.; Sofinnova Management IX, L.L.C.; Mehra Anand; HEALY JAMES","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":36.75,"price_display":"36.75","price_state":"stated","total_value":5512500.0,"total_display":"5,512,500.00","total_whole":"5,512,500","shares_owned_after":2671856.0,"shares_owned_after_display":"2,671,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-19","scope":"insider"},{"id":7775857,"accession":"0000899243-19-027116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027116","line_url":"/filing/0000899243-19-027116#line-2","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Venture Partners IX, L.P.; POWELL MICHAEL; Mehra Anand; HEALY JAMES; Sofinnova Management IX, L.L.C.","owner_display_name":"Sofinnova Venture Partners IX, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":9000000.0,"total_display":"9,000,000.00","total_whole":"9,000,000","shares_owned_after":3083712.0,"shares_owned_after_display":"3,083,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-12","scope":"insider"},{"id":7974444,"accession":"0001144204-19-026681","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-19-026681","line_url":"/filing/0001144204-19-026681#line-5","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"NextCure, Inc.","issuer_ticker":"NXTC","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Management IX, L.L.C.; HEALY JAMES; Mehra Anand; Sofinnova Venture Partners IX, L.P.; POWELL MICHAEL","owner_display_name":"Sofinnova Management IX, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","total_whole":"6,000,000","shares_owned_after":2521856.0,"shares_owned_after_display":"2,521,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":6347601,"accession":"0001144204-18-055025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-055025","line_url":"/filing/0001144204-18-055025#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":372093.0,"shares_display":"372,093","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":3999999.75,"total_display":"3,999,999.75","total_whole":"4,000,000","shares_owned_after":1911573.0,"shares_owned_after_display":"1,911,573","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-22","filed_date":"2018-10-23","scope":"insider"},{"id":5966240,"accession":"0001209191-18-053539","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-053539","line_url":"/filing/0001209191-18-053539#line-3","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Entasis Therapeutics Holdings Inc.","issuer_ticker":"ETTX","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Mehra Anand; HEALY JAMES; Sofinnova Management IX, L.L.C.; POWELL MICHAEL; Sofinnova Venture Partners IX, L.P.","owner_display_name":"Mehra Anand","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":337724.0,"shares_display":"337,724","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":5065860.0,"total_display":"5,065,860.00","total_whole":"5,065,860","shares_owned_after":1180178.0,"shares_owned_after_display":"1,180,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-28","filed_date":"2018-10-02","scope":"insider"},{"id":6707789,"accession":"0001209191-18-051838","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-051838","line_url":"/filing/0001209191-18-051838#line-5","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; HEALY JAMES; Sofinnova Management VIII, L.L.C.; Mehra Anand; Sofinnova Venture Partners VIII, L.P.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":270000.0,"shares_display":"270,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4590000.0,"total_display":"4,590,000.00","total_whole":"4,590,000","shares_owned_after":2038208.0,"shares_owned_after_display":"2,038,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":6228747,"accession":"0001144204-18-031803","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-18-031803","line_url":"/filing/0001144204-18-031803#line-4","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Management IX, L.L.C.; Mehra Anand; Sofinnova Venture Partners IX, L.P.; POWELL MICHAEL","owner_display_name":"Sofinnova Management IX, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":6500000.0,"total_display":"6,500,000.00","total_whole":"6,500,000","shares_owned_after":1726514.0,"shares_owned_after_display":"1,726,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider"},{"id":4617240,"accession":"0001144204-17-038426","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-17-038426","line_url":"/filing/0001144204-17-038426","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211858.0,"shares_display":"211,858","price_per_share":70.15072765720436,"price_display":"70.15","price_state":"stated","total_value":14861992.86,"total_display":"14,861,992.86","total_whole":"14,861,993","shares_owned_after":493817.0,"shares_owned_after_display":"493,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-24","filed_date":"2017-07-26","scope":"insider","n_lines":4},{"id":4819341,"accession":"0001144204-17-033672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-033672","line_url":"/filing/0001144204-17-033672#line-2","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5282.0,"shares_display":"5,282","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":343330.0,"total_display":"343,330.00","total_whole":"343,330","shares_owned_after":693128.0,"shares_owned_after_display":"693,128","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-21","filed_date":"2017-06-22","scope":"insider"},{"id":4819327,"accession":"0001144204-17-033672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-033672","line_url":"/filing/0001144204-17-033672#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1020.0,"shares_display":"1,020","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":66300.0,"total_display":"66,300.00","total_whole":"66,300","shares_owned_after":698410.0,"shares_owned_after_display":"698,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-20","filed_date":"2017-06-22","scope":"insider"},{"id":4594745,"accession":"0001144204-17-013027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-013027","line_url":"/filing/0001144204-17-013027#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15275.0,"shares_display":"15,275","price_per_share":65.01,"price_display":"65.01","price_state":"stated","total_value":993027.75,"total_display":"993,027.75","total_whole":"993,028","shares_owned_after":699430.0,"shares_owned_after_display":"699,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-06","scope":"insider"},{"id":5363703,"accession":"0001144204-17-012259","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-17-012259","line_url":"/filing/0001144204-17-012259#line-3","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17470.0,"shares_display":"17,470","price_per_share":65.01,"price_display":"65.01","price_state":"stated","total_value":1135724.7,"total_display":"1,135,724.70","total_whole":"1,135,725","shares_owned_after":714705.0,"shares_owned_after_display":"714,705","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-01","scope":"insider"},{"id":5363700,"accession":"0001144204-17-012259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-012259","line_url":"/filing/0001144204-17-012259#line-2","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25274.0,"shares_display":"25,274","price_per_share":65.02,"price_display":"65.02","price_state":"stated","total_value":1643315.48,"total_display":"1,643,315.48","total_whole":"1,643,315","shares_owned_after":732175.0,"shares_owned_after_display":"732,175","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":5363694,"accession":"0001144204-17-012259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-012259","line_url":"/filing/0001144204-17-012259#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41910.0,"shares_display":"41,910","price_per_share":65.02,"price_display":"65.02","price_state":"stated","total_value":2724988.2,"total_display":"2,724,988.20","total_whole":"2,724,988","shares_owned_after":757449.0,"shares_owned_after_display":"757,449","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":5075292,"accession":"0001144204-17-010436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-010436","line_url":"/filing/0001144204-17-010436#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7535.0,"shares_display":"7,535","price_per_share":65.01,"price_display":"65.01","price_state":"stated","total_value":489850.35,"total_display":"489,850.35","total_whole":"489,850","shares_owned_after":799359.0,"shares_owned_after_display":"799,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-17","filed_date":"2017-02-22","scope":"insider"},{"id":4173541,"accession":"0001144204-17-009684","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-17-009684","line_url":"/filing/0001144204-17-009684#line-3","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":65.01,"price_display":"65.01","price_state":"stated","total_value":188529.0,"total_display":"188,529.00","total_whole":"188,529","shares_owned_after":806894.0,"shares_owned_after_display":"806,894","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-16","scope":"insider"},{"id":4173539,"accession":"0001144204-17-009684","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-009684","line_url":"/filing/0001144204-17-009684#line-2","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31497.0,"shares_display":"31,497","price_per_share":65.03,"price_display":"65.03","price_state":"stated","total_value":2048249.91,"total_display":"2,048,249.91","total_whole":"2,048,250","shares_owned_after":809794.0,"shares_owned_after_display":"809,794","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-02-16","scope":"insider"},{"id":4173536,"accession":"0001144204-17-009684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-009684","line_url":"/filing/0001144204-17-009684#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":950.0,"shares_display":"950","price_per_share":65.02,"price_display":"65.02","price_state":"stated","total_value":61769.0,"total_display":"61,769.00","total_whole":"61,769","shares_owned_after":841291.0,"shares_owned_after_display":"841,291","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-02-16","scope":"insider"},{"id":5022516,"accession":"0001144204-17-008080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-008080","line_url":"/filing/0001144204-17-008080#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37411.0,"shares_display":"37,411","price_per_share":65.06,"price_display":"65.06","price_state":"stated","total_value":2433959.66,"total_display":"2,433,959.66","total_whole":"2,433,960","shares_owned_after":842241.0,"shares_owned_after_display":"842,241","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-13","scope":"insider"},{"id":5075260,"accession":"0001144204-17-006569","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-17-006569","line_url":"/filing/0001144204-17-006569#line-3","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1994.0,"shares_display":"1,994","price_per_share":65.04,"price_display":"65.04","price_state":"stated","total_value":129689.76,"total_display":"129,689.76","total_whole":"129,690","shares_owned_after":879652.0,"shares_owned_after_display":"879,652","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-07","filed_date":"2017-02-07","scope":"insider"},{"id":5075256,"accession":"0001144204-17-006569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-006569","line_url":"/filing/0001144204-17-006569#line-2","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1010.0,"shares_display":"1,010","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":65650.0,"total_display":"65,650.00","total_whole":"65,650","shares_owned_after":881646.0,"shares_owned_after_display":"881,646","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-07","scope":"insider"},{"id":5075252,"accession":"0001144204-17-006569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-006569","line_url":"/filing/0001144204-17-006569#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22330.0,"shares_display":"22,330","price_per_share":65.06,"price_display":"65.06","price_state":"stated","total_value":1452789.8,"total_display":"1,452,789.80","total_whole":"1,452,790","shares_owned_after":882656.0,"shares_owned_after_display":"882,656","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-07","scope":"insider"},{"id":5180683,"accession":"0001144204-17-002042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-002042","line_url":"/filing/0001144204-17-002042#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750000.0,"shares_display":"750,000","price_per_share":28.2511,"price_display":"28.25","price_state":"stated","total_value":21188325.0,"total_display":"21,188,325.00","total_whole":"21,188,325","shares_owned_after":1539480.0,"shares_owned_after_display":"1,539,480","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-10","filed_date":"2017-01-12","scope":"insider"},{"id":2566108,"accession":"0001144204-16-140371","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-140371","line_url":"/filing/0001144204-16-140371","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":279728.0,"shares_display":"279,728","price_per_share":53.55492935994967,"price_display":"53.55","price_state":"stated","total_value":14980813.28,"total_display":"14,980,813.28","total_whole":"14,980,813","shares_owned_after":954986.0,"shares_owned_after_display":"954,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-19","scope":"insider","n_lines":2},{"id":2566098,"accession":"0001144204-16-140371","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-140371","line_url":"/filing/0001144204-16-140371#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69928.0,"shares_display":"69,928","price_per_share":53.07,"price_display":"53.07","price_state":"stated","total_value":3711078.96,"total_display":"3,711,078.96","total_whole":"3,711,079","shares_owned_after":1184714.0,"shares_owned_after_display":"1,184,714","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-19","scope":"insider"},{"id":2803651,"accession":"0001144204-16-139271","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-16-139271","line_url":"/filing/0001144204-16-139271#line-6","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22281.0,"shares_display":"22,281","price_per_share":53.32,"price_display":"53.32","price_state":"stated","total_value":1188022.92,"total_display":"1,188,022.92","total_whole":"1,188,023","shares_owned_after":1254642.0,"shares_owned_after_display":"1,254,642","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-13","filed_date":"2016-12-13","scope":"insider"},{"id":2803645,"accession":"0001144204-16-139271","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-16-139271","line_url":"/filing/0001144204-16-139271","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100251.0,"shares_display":"100,251","price_per_share":55.57582517880121,"price_display":"55.58","price_state":"stated","total_value":5571532.05,"total_display":"5,571,532.05","total_whole":"5,571,532","shares_owned_after":1276923.0,"shares_owned_after_display":"1,276,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-09","filed_date":"2016-12-13","scope":"insider","n_lines":5},{"id":3125948,"accession":"0001144204-16-129201","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-129201","line_url":"/filing/0001144204-16-129201","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; Sofinnova Venture Affiliates VI LP; HEALY JAMES; Buatois Eric; SOFINNOVA VENTURE PARTNERS VI L P; Mehra Anand; Sofinnova Venture Partners VI GmbH & Co. KG; Azan Alain; Sofinnova Management VI, L.L.C.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750683.0,"shares_display":"750,683","price_per_share":1.389,"price_display":"1.39","price_state":"stated","total_value":1042698.687,"total_display":"1,042,698.69","total_whole":"1,042,699","shares_owned_after":1134851.0,"shares_owned_after_display":"1,134,851","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-20","filed_date":"2016-10-24","scope":"insider","n_lines":3},{"id":2197089,"accession":"0001144204-16-118759","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-118759","line_url":"/filing/0001144204-16-118759","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23063.0,"shares_display":"23,063","price_per_share":60.16905086068595,"price_display":"60.17","price_state":"stated","total_value":1387678.82,"total_display":"1,387,678.82","total_whole":"1,387,679","shares_owned_after":1377674.0,"shares_owned_after_display":"1,377,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-11","filed_date":"2016-08-12","scope":"insider","n_lines":2},{"id":2197079,"accession":"0001144204-16-118759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-118759","line_url":"/filing/0001144204-16-118759#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6900.0,"shares_display":"6,900","price_per_share":60.02,"price_display":"60.02","price_state":"stated","total_value":414138.0,"total_display":"414,138.00","total_whole":"414,138","shares_owned_after":1400237.0,"shares_owned_after_display":"1,400,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-10","filed_date":"2016-08-12","scope":"insider"},{"id":2803296,"accession":"0001144204-16-118104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-118104","line_url":"/filing/0001144204-16-118104#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":60.47,"price_display":"60.47","price_state":"stated","total_value":6047.0,"total_display":"6,047.00","total_whole":"6,047","shares_owned_after":1407137.0,"shares_owned_after_display":"1,407,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-08","filed_date":"2016-08-10","scope":"insider"},{"id":2966824,"accession":"0001144204-16-116981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-116981","line_url":"/filing/0001144204-16-116981#line-2","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":452.0,"shares_display":"452","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":27120.0,"total_display":"27,120.00","total_whole":"27,120","shares_owned_after":1407237.0,"shares_owned_after_display":"1,407,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-04","filed_date":"2016-08-05","scope":"insider"},{"id":2966820,"accession":"0001144204-16-116981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-116981","line_url":"/filing/0001144204-16-116981#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4612.0,"shares_display":"4,612","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":276720.0,"total_display":"276,720.00","total_whole":"276,720","shares_owned_after":1407689.0,"shares_owned_after_display":"1,407,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-03","filed_date":"2016-08-05","scope":"insider"},{"id":2040693,"accession":"0001144204-16-116325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-116325","line_url":"/filing/0001144204-16-116325#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22665.0,"shares_display":"22,665","price_per_share":60.03,"price_display":"60.03","price_state":"stated","total_value":1360579.95,"total_display":"1,360,579.95","total_whole":"1,360,580","shares_owned_after":1412301.0,"shares_owned_after_display":"1,412,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":2350268,"accession":"0001144204-16-106469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-106469","line_url":"/filing/0001144204-16-106469#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":1434966.0,"shares_owned_after_display":"1,434,966","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider"},{"id":8647952,"accession":"0001144204-15-068658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-068658","line_url":"/filing/0001144204-15-068658#line-2","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5350.0,"shares_display":"5,350","price_per_share":60.02,"price_display":"60.02","price_state":"stated","total_value":321107.0,"total_display":"321,107.00","total_whole":"321,107","shares_owned_after":1435466.0,"shares_owned_after_display":"1,435,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-27","filed_date":"2015-11-30","scope":"insider"},{"id":8647950,"accession":"0001144204-15-068658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-068658","line_url":"/filing/0001144204-15-068658#line-1","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17611.0,"shares_display":"17,611","price_per_share":60.01,"price_display":"60.01","price_state":"stated","total_value":1056836.11,"total_display":"1,056,836.11","total_whole":"1,056,836","shares_owned_after":1440816.0,"shares_owned_after_display":"1,440,816","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-25","filed_date":"2015-11-30","scope":"insider"},{"id":8800720,"accession":"0001144204-15-064912","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-15-064912","line_url":"/filing/0001144204-15-064912#line-4","is_derivative":false,"issuer_cik":"0001590102","issuer_name":"Spark Therapeutics, Inc.","issuer_ticker":"ONCE","issuer_name_source":null,"issuer_url":"/issuer/0001590102","owner_cik":"0001590102","owner_name":"Mehra Anand","owner_display_name":"Mehra Anand","owner_url":"/insider/0001590102","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1074.0,"shares_display":"1,074","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":64440.0,"total_display":"64,440.00","total_whole":"64,440","shares_owned_after":1458427.0,"shares_owned_after_display":"1,458,427","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-12","filed_date":"2015-11-12","scope":"insider"}],"collapsed":true,"next_cursor":"2015-11-12|8800720","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2015-10-13","last_seen":"2024-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001661059","name":"NextCure, Inc.","url":"/issuer/0001661059","role":"Ten percent owner","n_filings":2,"first_seen":"2019-05-15","last_seen":"2019-11-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001563577","name":"Galera Therapeutics, Inc.","url":"/issuer/0001563577","role":"Ten percent owner","n_filings":1,"first_seen":"2019-11-12","last_seen":"2019-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001724344","name":"Entasis Therapeutics Holdings Inc.","url":"/issuer/0001724344","role":"Ten percent owner","n_filings":1,"first_seen":"2018-10-02","last_seen":"2018-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Ten percent owner","n_filings":1,"first_seen":"2018-09-20","last_seen":"2018-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Ten percent owner","n_filings":1,"first_seen":"2018-05-30","last_seen":"2018-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001609351","name":"Spark Therapeutics, Inc.","url":"/issuer/0001609351","role":"Director","n_filings":19,"first_seen":"2015-02-06","last_seen":"2017-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001267813","name":"MARINUS PHARMACEUTICALS INC","url":"/issuer/0001267813","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2014-08-07","last_seen":"2016-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001527599","name":"Mirna Therapeutics, Inc.","url":"/issuer/0001527599","role":"Ten percent owner","n_filings":1,"first_seen":"2015-10-06","last_seen":"2015-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001339970","name":"aTYR PHARMA INC","url":"/issuer/0001339970","role":"Ten percent owner","n_filings":1,"first_seen":"2015-05-14","last_seen":"2015-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001337553","name":"AERIE PHARMACEUTICALS INC","url":"/issuer/0001337553","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2013-10-30","last_seen":"2015-04-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001372299","name":"HISTOGENICS CORP","url":"/issuer/0001372299","role":"Ten percent owner","n_filings":1,"first_seen":"2014-12-10","last_seen":"2014-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001513818","name":"Versartis, Inc.","url":"/issuer/0001513818","role":"Ten percent owner","n_filings":1,"first_seen":"2014-03-28","last_seen":"2014-03-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001590102","retrieved_at":"2026-08-22T13:21:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}